News & Events


Green Cross Pharmaceuticals,·Venture Capital, Invest $12 million in AI Healthcare

VUNO has received $12 million in Series B funding. In this round, 4 venture capital funds and...

VUNO Med®-DEWS to be commercially available in May 2019

Korean startup, Vuno will provide a cardiac arrest AI detection tool to be commercially...

Sejong Medical Center/Philips Korea/VUNO AI MOU

Sejong Medical Center, Philips Korea, and Vuno have created an MOU to develop AI based...

The paper, VUNO published with Mediplex Sejong, has been featured in JAHA

The paper, VUNO published with Mediplex Sejong, has been featured in JAHA.DEWS (Deep learning...

VUNO Med®-BoneAge is the first in Korea to receive MFDS approval.

Ministry of Food and Drug Safety(MFDS) has approved VUNO Med®-BoneAge,AI-based diagnostic...

The medical artificial intelligence(AI) society will be established for the first time in Korea.

The Medical Artificial Intelligence society will be established for the first time in Korea.It...

Korea's first AI medical device MFDS approval is just around the corner.

Korea's first Artificial Intelligence (AI) diagnostic support system has been approved. As early...

CEO of VUNO, appointed as a member of PACST

Yeha Lee, Ph.D., the CEO of VUNO, has been appointed as one of 12 members of Presidential...

Successful exhibit at RSNA2017

VUNO participated in the RSNA this year for the second time, and introduced various AI-based...

WELCOME!

Thanks for subscribing to our newsletter.